Wells Fargo’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303 | Sell |
244
-17,205
| -99% | -$21.4K | ﹤0.01% | 5957 |
|
|
2025
Q1 | $21.3K | Buy |
17,449
+387
| +2% | +$472 | ﹤0.01% | 5235 |
|
|
2024
Q4 | $30.7K | Buy |
17,062
+3,814
| +29% | +$6.87K | ﹤0.01% | 5138 |
|
|
2024
Q3 | $67.4K | Buy |
13,248
+10,099
| +321% | +$51.4K | ﹤0.01% | 4829 |
|
|
2024
Q2 | $22.4K | Buy |
3,149
+3,099
| +6,198% | +$22K | ﹤0.01% | 5176 |
|
|
2024
Q1 | $137 | Buy |
50
+2
| +4% | +$5 | ﹤0.01% | 6193 |
|
|
2023
Q4 | $130 | Buy |
48
+3
| +7% | +$8 | ﹤0.01% | 6261 |
|
|
2023
Q3 | $118 | Hold |
45
| – | – | ﹤0.01% | 6350 |
|
|
2023
Q2 | $126 | Buy |
45
+3
| +7% | +$8 | ﹤0.01% | 6512 |
|
|
2023
Q1 | $122 | Hold |
42
| – | – | ﹤0.01% | 6572 |
|
|
2022
Q4 | $154 | Buy |
42
+1
| +2% | +$4 | ﹤0.01% | 6368 |
|
|
2022
Q3 | $0 | Sell |
41
-3
| -7% | – | ﹤0.01% | 7182 |
|
|
2022
Q2 | $0 | Sell |
44
-3,674
| -99% | – | ﹤0.01% | 7287 |
|
|
2022
Q1 | $31K | Sell |
3,718
-2,706
| -42% | -$22.6K | ﹤0.01% | 5520 |
|
|
2021
Q4 | $67K | Buy |
6,424
+6,393
| +20,623% | +$66.7K | ﹤0.01% | 5398 |
|
|
2021
Q3 | $1K | Buy |
+31
| New | +$1K | ﹤0.01% | 6482 |
|